+ All Categories
Home > Documents > Reclast Infusion Center Analysis August 4, 2008

Reclast Infusion Center Analysis August 4, 2008

Date post: 03-Jan-2016
Category:
Upload: asher-ellison
View: 28 times
Download: 0 times
Share this document with a friend
Description:
Reclast Infusion Center Analysis August 4, 2008. Key Findings. 93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district. 45.1K targets have infusion access within 10 miles - PowerPoint PPT Presentation
16
1 Reclast Infusion Center Analysis August 4, 2008
Transcript
Page 1: Reclast Infusion Center Analysis August 4, 2008

1

ReclastInfusion Center Analysis

August 4, 2008

ReclastInfusion Center Analysis

August 4, 2008

Page 2: Reclast Infusion Center Analysis August 4, 2008

2

Key Findings

93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district.• 45.1K targets have infusion access within 10 miles• 3.3K targets do not have infusion access within 10 miles

There is a positive relationship between Reclast sales and the number of infusion centers • As the number of infusion centers increases, Reclast sales increase

Page 3: Reclast Infusion Center Analysis August 4, 2008

3

Infusion Center Access in Geigy Regions

Page 4: Reclast Infusion Center Analysis August 4, 2008

4

Geigy Region: Atlanta 5,821 targets have infusion access within 10 miles (black dots)

428 targets do not have infusion access within 10 miles (red triangles)

Page 5: Reclast Infusion Center Analysis August 4, 2008

5

Geigy Region: Boston 4.606 targets have infusion access within 10 miles (black dots)

218 targets do not have infusion access within 10 miles (red triangles)

Page 6: Reclast Infusion Center Analysis August 4, 2008

6

Geigy Region: Chicago 7,426 targets have infusion access within 10 miles (black dots)

550 targets do not have infusion access within 10 miles (red triangles)

Page 7: Reclast Infusion Center Analysis August 4, 2008

7

Geigy Region: Cincinnati 6,339 targets have infusion access within 10 miles (black dots)

350 targets do not have infusion access within 10 miles (red triangles)

Page 8: Reclast Infusion Center Analysis August 4, 2008

8

Geigy Region: Dallas 5,661 targets have infusion access within 10 miles (black dots)

573 targets do not have infusion access within 10 miles (red triangles)

Page 9: Reclast Infusion Center Analysis August 4, 2008

9

Geigy Region: Morristown 4,828 targets have infusion access within 10 miles (black dots)

278 targets do not have infusion access within 10 miles (red triangles)

Page 10: Reclast Infusion Center Analysis August 4, 2008

10

Geigy Region: Raleigh 5,141 targets have infusion access within 10 miles (black dots)

512 targets do not have infusion access within 10 miles (red triangles)

Page 11: Reclast Infusion Center Analysis August 4, 2008

11

Geigy Region: San Ramon 5,109 targets have infusion access within 10 miles (black dots)

307 targets do not have infusion access within 10 miles (red triangles)

Page 12: Reclast Infusion Center Analysis August 4, 2008

13

Relationship between Reclast Sales and Infusion Access Using Bone-Uro District Data

Page 13: Reclast Infusion Center Analysis August 4, 2008

15

Bone/Uro Districts: Correlation between Reclast sales and Reclast Ready sites is 0.60

There is a positive association between Reclast sales and Reclast Ready sites

0

100

200

300

400

500

600

700

KA

NS

AS

CIT

Y

NA

SH

VIL

LE

AT

LA

NT

A

DE

TR

OIT

TA

MP

A

PIT

TS

BU

RG

H

CH

ICA

GO

HO

US

TO

N

BO

ST

ON

SA

N F

RA

NC

ISC

O

WA

SH

ING

TO

N D

C

PH

ILA

DE

LP

HIA

DA

LL

AS

LO

S A

NG

EL

ES

NE

W Y

OR

K

Re

cla

st R

ea

dy

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

1.8

%R

ecla

st S

ale

s/%

BP

TR

xs

Reclast Ready %Reclast Sales/%BP TRxs

Data ending June 2008

Page 14: Reclast Infusion Center Analysis August 4, 2008

17

Bone/Uro Districts: Correlation between Reclast sales and estimated 65+ women patients per Reclast Ready facility is -0.76 There is a positive association between sales and Reclast Ready sites

0

500

1,000

1,500

2,000

2,500

3,000

3,500

4,000

4,500

5,000

KA

NS

AS

CIT

Y

NA

SH

VIL

LE

AT

LA

NT

A

DE

TR

OIT

TA

MP

A

PIT

TS

BU

RG

H

CH

ICA

GO

HO

US

TO

N

BO

ST

ON

SA

N F

RA

NC

ISC

O

WA

SH

ING

TO

N D

C

PH

ILA

DE

LP

HIA

DA

LL

AS

LO

S A

NG

EL

ES

NE

W Y

OR

K

Pa

tie

nts

/RR

Fa

cility

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

1.8

%R

ecla

st S

ale

s/%

BP

TR

xs

Est. 65+ Women Patient per RR Facility %Reclast Sales/%BP TRxs

Estimated 65+ Women Patients = 55% of 65+ Women

Data ending June 2008

Page 15: Reclast Infusion Center Analysis August 4, 2008

18

Bone-Uro Districts: Correlation between estimated 65+ women patients and oral BP TRxs is 0.90 but correlation between 65+ Women patients and Reclast sales is only 0.42

0

500,000

1,000,000

1,500,000

2,000,000

2,500,000

3,000,000

3,500,000K

AN

SA

S C

ITY

NA

SH

VIL

LE

AT

LA

NT

A

DE

TR

OIT

TA

MP

A

PIT

TS

BU

RG

H

CH

ICA

GO

HO

US

TO

N

BO

ST

ON

SA

N F

RA

NC

ISC

O

WA

SH

ING

TO

N D

C

PH

ILA

DE

LP

HIA

DA

LL

AS

LO

S A

NG

EL

ES

NE

W Y

OR

K

Ora

l B

P T

Rxs &

Est. 6

5+

W P

atie

nts

$0

$2

$4

$6

$8

$10

$12

Millio

ns

Re

cla

st S

ale

s

Est. 65+ Women Patients BPTRX Reclast Sales

Estimated 65+ Women Patients = 55% of 65+ Women

Data ending June 2008

Page 16: Reclast Infusion Center Analysis August 4, 2008

19

Back-UpInfusion Center Access in Bone-Uro Districts


Recommended